A day in the life of a nebulizer: Surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting

Respiratory Care

Volumn 52, Issue 3, 2007, Pages 258-262

  O'Malley, Catherine A ^a,b   VandenBranden, Stacy L ^a   Zheng, Xiaotian T ^a   Polito, Anne M ^a   McColley, Susanna A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Aerosol; Contamination; Cystic fibrosis; Disposable; Infection control; Nebulizer; Respiratory equipment

Indexed keywords

IPRATROPIUM BROMIDE; LEVALBUTEROL; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; BACILLUS; BACTERIAL GROWTH; BURKHOLDERIA CEPACIA; CANDIDA ALBICANS; CHILD; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CORYNEBACTERIUM; CYSTIC FIBROSIS; DEVICE INFECTION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; MICROBIAL CONTAMINATION; NEBULIZER; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; THROAT CULTURE; BACTERIUM; CROSS INFECTION; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; INFANT; MICROBIOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; BACTERIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; NEBULIZERS AND VAPORIZERS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 34247121955     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Pitchford KC, Corey M, Highsmith AK, Perlman R, Bannatyne R, Gold R, et al. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr 1987;111(2):212-216.
2. Saiman L, Siegel J; Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003;24(5 Suppl):S6-S52.
3. Denton M, Rajgopal A, Mooney L, Qureshi A, Kerr KG, Keer V, et al. Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis. J Hosp Infect 2003;55(3):180-183.
4. American Association for Respiratory Care. AARC Clinical Practice Guideline: Selection of aerosol delivery device. Respir Care 1992;37(8):891-897. (retired August 2006)
5. American Association for Respiratory Care. AARC Clinical Practice Guideline: Selection of a device for delivery of aerosol to the lung parenchyma. Respir Care 1996;41(7):647-653.
6. American Association for Respiratory Care. AARC Clinical Practice Guideline: Delivery of aerosols to the upper airway. Respir Care 1994;39(8):803-807. (retired August 2004)
7. American Association for Respiratory Care. Clinical Practice Guideline: Selection of an aerosol delivery device for neonatal and pediatric patients. Respir Care 1995;40(12):1325-1335.